KU Cancer Center-invented drug could eliminate need for bladder removal

CicloMed LLC has expanded a clinical trial for an anti-cancer drug that could potentially transform the treatment of bladder cancer. Researchers at the University of Kansas Cancer Center and its Institute for Advancing Medical Innovation (IAMI) first discovered the treatment several years ago. Now, the drug is licensed out to CicloMed, a Kansas City-based biotechnology company formed by IAMI and Kansas City venture capital firm BioNovus Innovations LLC. Fosciclopirox is set to become the first…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news